A multicenter, single‐arm, open‐label interventional study of adherence to brexpiprazole during switching from previous antipsychotic drugs in patients with schizophrenia or schizoaffective disorder

Documenti analoghi

• Feasibility of remote interviews in assessing disease severity in patients with major depressive disorder: A pilot study
  di: Tomiki Sumiyoshi, et al.
  Pubblicazione: (2024)
• Constipation‐associated factors in outpatients with schizophrenia: A multicenter questionnaire survey
  di: Taro Tazaki, et al.
  Pubblicazione: (2024)
• A psychometric analysis of the Japanese version of the clinically useful depression outcome scale supplemented with questions for the DSM‐5 anxious distress specifier (CUDOS‐A)
  di: Yumi Aoki, et al.
  Pubblicazione: (2024)
• Comparison of brexpiprazole, aripiprazole, and placebo for Japanese major depressive disorder: A systematic review and network meta‐analysis
  di: Taro Kishi, et al.
  Pubblicazione: (2024)
• Nonrandomized Allocation of Steroid Therapy in Patients With Fukuyama Congenital Muscular Dystrophy: Study Protocol for a Phase II Clinical Trial
  di: Terumi Murakami, et al.
  Pubblicazione: (2025)